Ascendiant Capital Markets, LLC

Ascendiant News

See Our Impact

Need capital to meet your growth plans? Get in touch with our team today!

Ascendiant Capital Markets LLC to Attend JPM Week in San Francisco, January 13-15, 2025

JUPITER, Florida – January 10, 2025 — Ascendiant Capital Markets LLC (“Ascendiant”) announced plans to participate in the JPM Week healthcare conferences in San Francisco, California, January 13-15, 2025.

Ascendiant’s Investment Banking and Equity Research teams will be meeting with public companies listed on the Nasdaq and the NYSE American stock exchanges, institutional investors, investor relations firms, securities attorneys, auditors, and other professionals.

To connect with Ascendiant during JPM Week, please contact Bradley J. Wilhite, Co-Founder & Managing Partner, at 561.427.1727 or bwilhite@ascendiant.com.

To view this announcement, click here.

Share this post with your friends:

Facebook
Twitter
LinkedIn

Want to stay up-to-date with the latest at Ascendiant? Subscribe to our mailing list!

Newsletter Form (#2)

See other recent news

January 10, 2025
Ascendiant Capital Markets LLC to Attend JPM Week in San Francisco, January 13-15, 2025
October 28, 2024
Ascendiant Capital Markets LLC Serves as Sole Sales Agent on $21,340,000 At-the-Market (ATM) Offering for Giftify, Inc. (Nasdaq: GIFT)
October 10, 2024
Ascendiant Initiates Equity Research Coverage on GRI Bio, Inc. (Nasdaq: GRI)
October 7, 2024
Ascendiant Capital Markets LLC Serves as Sole Sales Agent on $6,500,000 At-the-Market (ATM) Offering for Alzamend Neuro, Inc. (Nasdaq: ALZN)
September 30, 2024
Ascendiant Capital Markets LLC announced today the filing of a $1,075,000 At-the-Market (ATM) Offering for Aclarion, Inc. (Nasdaq: ACON) of Broomfield, Colorado
September 16, 2024
Ascendiant Capital Markets LLC Serves as Sole Sales Agent on $2,600,000 At-the-Market (ATM) Offering for Auddia Inc. (Nasdaq: AUUD)
September 12, 2024
Ascendiant Serves as Financial Advisor on $2,510,000 Private Placement for Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS)
September 9, 2024
Ascendiant Capital Markets LLC’s At-the-Market (ATM) Offering for Allarity Therapeutics, Inc. (Nasdaq: ALLR) Increased to $50,000,000
September 3, 2024
Ascendiant Completes 23rd Year in Business, Moves Forward Into Year 24
August 26, 2024
Ascendiant Capital Markets LLC Serves as Sole Placement Agent on $3,150,000 Private Placement for Allarity Therapeutics, Inc. (Nasdaq: ALLR)
August 19, 2024
Ascendiant Capital Markets LLC Serves as Sole Placement Agent on $8,250,000 Private Placement for Quantum Computing Inc. (Nasdaq: QUBT)
August 12, 2024
Ascendiant Capital Markets LLC’s At-the-Market (ATM) Offering for The Singing Machine Company, Inc. (Nasdaq: MICS) Increased to $3,100,000